(Q34521587)

2 August 2017

1 reference

title

Oral lesions of HIV disease and HAART in industrialized countries (English)

1 reference

2 August 2017

T A Hodgson

1

1 reference

2 August 2017

D Greenspan

series ordinal

2

1 reference

2 August 2017

J S Greenspan

series ordinal

3

1 reference

2 August 2017

language of work or name

1 reference

1 April 2006

1 reference

Advances in Dental Research

2 August 2017

published in

1 reference

2 August 2017

volume

19

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

57-62

1 reference

Long-term follow-up of didanosine administered orally twice daily to patients with advanced human immunodeficiency virus infection and hematologic intolerance of zidovudine

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Prognostic significance of HIV-associated oral lesions and their relation to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Medication usage and dental caries outcome-related variables in HIV/AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Antiretroviral therapy with protease inhibitors has an early, immune reconstitution-independent beneficial effect on Candida virulence and oral candidiasis in human immunodeficiency virus-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Risk indicators for oral candidiasis and oral hairy leukoplakia in HIV-infected adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Oral conditions and their social impact among HIV dental patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Associations of self-reported oral health with physical and mental health in a nationally representative sample of HIV persons receiving medical care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

A qualitative exploration of dental practitioners' knowledge, attitudes and practices towards HIV+ and patients with other 'high risk' groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

The accurate diagnosis of oral lesions in human immunodeficiency virus infection. Impact on medical staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Oral manifestations of an HIV positive cohort in the era of highly active anti-retroviral therapy (HAART) in South London.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

AIDS and infection control in dental practice: dentists' attitudes, knowledge, and behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Effect of highly active antiretroviral therapy on frequency of oral warts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Incidence of oral lesions in HIV-1-infected women: reduction with HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Sentinels and signposts: the epidemiology and significance of the oral manifestations of HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

The epidemiology of the oral lesions of HIV infection in the developed world

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Oral manifestations of HIV infection. Definitions, diagnostic criteria, and principles of therapy. The U.S.A. Oral AIDS Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Changes in the prevalence of HIV-associated mucosal disease at a dedicated clinic over 7 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

The role of human papillomavirus in oral carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Human papillomavirus infection and disease in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Development of oral lesions in human immunodeficiency virus-infected transfusion recipients and hemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Accuracy of diagnoses of HIV-related oral lesions by medical clinicians. Findings from the Women's Interagency HIV Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Oral fungal and bacterial infections in HIV-infected individuals: an overview in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

(A1) Identification of oral health care needs in children and adults, management of oral diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Oral lesions of HIV infection in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Oral hairy leukoplakia in 71 HIV-seropositive patients: clinical symptoms, relation to immunologic status, and prognostic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Refractory human papillomavirus-associated oral warts treated topically with 1-3% cidofovir solutions in human immunodeficiency virus type 1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Oral cavity and oropharyngeal tumors in human immunodeficiency virus-positive patients: acute response to radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Human papillomavirus-associated oral warts among human immunodeficiency virus-seropositive patients in the era of highly active antiretroviral therapy: an emerging infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Enfuvirtide: a new class of antiretroviral therapy for HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Associations of symptoms and health-related quality of life: findings from a national study of persons with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Intraoral non-Hodgkin's lymphoma in seven patients with acquired immunodeficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

HIV infection and advanced age emerging epidemiological, clinical, and management issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Dermatologic complications associated with administration of 2',3'-dideoxycytidine in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Epidemiology, clinical features and prognostic value of HIV-1 related oral lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Dermatological findings correlated with CD4 lymphocyte counts in a prospective 3 year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Anti-fungal therapy at the HAART of viral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

A 4-year longitudinal evaluation of xerostomia and salivary gland hypofunction in the Women's Interagency HIV Study participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Ability of primary care physicians to recognize physical findings associated with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Oral hairy leukoplakia and oral candidiasis as predictors of HIV viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Dental caries in HIV-seropositive women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Recovery of the immune system with antiretroviral therapy: the end of opportunism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Predicting outcomes in HIV-infected veterans: II. Survival after AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

The Changing Clinical Spectrum of Human Immunodeficiency Virus (HIV)-Related Oral Lesions in 1,000 Consecutive Patients: A 12-Year Study in a Referral Center in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Dental considerations for the paediatric AIDS/HIV patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Oral lesions in HIV infection in developing countries: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Relationship of circulating CD4+ T-lymphocytes and p24 antigenemia to the risk of developing AIDS in HIV-infected subjects with oral hairy leukoplakia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Implications of HIV disease for oral health services

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Dental care of infectious patients in Denmark, 1986–1993: theoretical considerations and empirical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Oral lesions among women living with or at risk for HIV infection. HIV Epidemiology Research Study (HERS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Orofacial effects of antiretroviral therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Effect of receptive oral sex and smoking on the incidence of hairy leukoplakia in HIV-positive gay men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Thrush and fever as markers of immune competence in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Azole susceptibility patterns and genetic relationship among oral Candida strains isolated in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Expression of Epstein-Barr virus latent genes in oral epithelium: determinants of the pathogenesis of oral hairy leukoplakia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Association of Cancer With AIDS-Related Immunosuppression in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

Frequency of oropharyngeal candidiasis in HIV-infected patients on protease inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900112

10.1177/154407370601900112

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference